To evaluate the effects of oral delayed-release dimethyl fumarate ( DMF ; also known as gastro-resistant DMF ) on MRI lesion activity and load , atrophy , and magnetization transfer ratio ( MTR ) measures from the Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis ( CONFIRM ) study .